GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: Indicator of a high prevalence of LADA?

Diabetes Research and Clinical Practice

Volumn 49, Issue 1, 2000, Pages 33-40

  Schiel, R ^a   Muller U A ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Anti GAD; Diabetes long term complications; Diabetes mellitus; Latent autoimmune diabetes mellitus in adults (LADA); Type 1; Type 2

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; COMPLICATION; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; GERMANY; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; KIDNEY DISEASES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREVALENCE; RADIOIMMUNOASSAY; RETINAL DISEASES; SEROEPIDEMIOLOGIC STUDIES;

EID: 0343091516     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00139-X     Document Type: Article

References (34)

1. Eisenbarth G.S., Ziegler A.G. Type 1 diabetes mellitus. Weintraub B.D. Molecular Endocrinology: Basic Concepts and Clinical Correlations. 1995;269-282 Raven Press, New York.
2. Ziegler A.G., Ziegler R., Vardi P., Jackson R.A., Soeldner J.S., Eisenbarth G.S. Life table analysis of progression to diabetes of anti-insulin autoantibody positive relatives of type 1 diabetics. Diabetes. 38:1989;1320-1325.
3. Christie M.R., Brown T.J., Cassidy D. Binding of antibodies in sera from type I (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues: Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia. 35:1992;380-384.
4. Seissler J., Amann J., Mauch L. et al. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 92:1993;1394-1399.
5. Velloso L.A., Kämpe O., Hallberg A., Cristmanson L., Betsholtz C., Karlsson F.A. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type I diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J. Clin. Invest. 91:1993;2084-2090.
6. Bingley P.J., Cristie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A.M. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody positive relatives. Diabetes. 43:1994;1304-1310.
7. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37:1994;344-350.
8. Petersen J.S., Hejnaes K.R., Moody A. et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using simple radioligand assay. Diabetes. 43:1994;459-467.
9. Roll U., Christie M.R., Standl E., Ziegler A.G. Association of anti-GAD-antibodies with islet cell antibodies and insulin antibodies in first degree relatives of type 1 diabetic patients. Diabetes. 44:1994;154-160.
10. E. Bonifacio, S. Genovese, S. Braghi, Bazzigaluppi, V. Lampasona, P.J. Bingley, L. Rogge, M.R. Pastore, E. Bognetti, G.F. Bottazzo, E.A.M. Gale, E. Bosi, Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity, Diabetologia 38 (1995) 816-822.
11. Mayrhofer M., Rabin D.U., Messenger L., Standl E., Ziegler A.G. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Exp. Clin. Endocrinol. Diabetes. 104:1996;228-234.
12. Baekkeskov S., Aanstoot H.J., Christgau S. et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
13. Solimena M., Dirkx R., Hermel J.M., Pleasic-Williams S., Shapiro J.A., Rabin D.U. ICA 512, an autoantigen of insulin-dependent diabetes mellitus is an ubiquitous intrinsic membrane protein of neurosecretory granules. EMBO J. 15:1996;2102-2114.
14. Wiest-Ladenburger U., Hartmann R., Hartmann U., Berling K., Böhm B.O., Richter W. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes. 46:1997;565-571.
15. Yu L., Gianini R., Eisenbarth G.S. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type 1 diabetes. Diabetes. 43:1994;1229-1233.
16. Schmidli R.S., DeAizpurua H.J., Harrison L.C., Colman P.G. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. J. Autoimmun. 7:1994;55-66.
17. Verge C.F., Howard N.J., Rowley M.J. et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia. 37:1994;1113-1120.
18. Tsuruoka A., Matsuba I., Toyota T., Isshiki G., Nagataki S., Ikeda Y. Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res. Clin. Pract. 28:1995;191-199.
19. K.G.M.M. Alberti, F.A. Gries, J. Jervell, H.M.J. Krans for the European NIDDM Policy Group, A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update, Diabetes Med. 11 (1994) 899-909.
20. Schiel R., Müller U.A., Janz H., Ross I.S. Health care for IDDM and NIDDM patients - Centralized versus non-centralized systems (JEVIN) (Abstract). Diabetologia. 39:1996;A201.
21. Schiel R., Müller U.A., Sprott H., Schmelzer A., Mertes B., Hunger-Dathe W., Ross I.S. The JEVIN-trial: A population-based survey on the quality of diabetes care in Germany - 1994/95 versus 1989/90. Diabetologia. 40:1997;1350-1357.
22. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus, Diabetes Care 20 (1997) 1183-1194.
23. Ziegler M., Strebelow M., Ziegler B., Weckermann R., Bergmann A. DIABEtest anti-GAD - ein Routineassay zur Bestimmung von GAD-Antikörpern als 1-Schritt-coated-tube RIA auf Basis monoklonaler GAD-Antikörper (Abstract). Diab. Stoffw. 5:1996;86.
24. Kohner E., Porta M. Screening for Diabetic Retinopathy in Europe: A Field Guide Book. 1992;WHO Regional Office for Europe, Copenhagen, Denmark.
25. Liniger C., Albeanu A., Bloise D., Assal J. The tuning fork revisited. Diabetes Med. 7:1990;859-864.
26. Young M.J., Boulton A.J.M., Macleod A.F., Williams D.R.R., Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 36:1993;150-154.
27. J. Seissler, N.G. Morgenthaler, P. Achenbach, E.F. Lampeter, D. Glawe, M. Payton, M. Christie, W.A. Scherbaum and the DENIS Study Group, Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM, Diabetologia 39 (1996) 1351-1356.
28. Lohmann T., Seissler J., Verlohren H.J., Schröder S., Rötger J., Dähn K., Morgenthaler N., Scherbaum W.A. Distinct genetic and immunological features in patients with insulin-dependent diabetes below and above age 40 at onset. Diabetes Care. 20:1997;524-529.
29. Zimmet P.Z., Tuomi T., Mackay I.R., Rowley M.J., Knowles W., Cohen M., Lang D.A. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetes Med. 11:1994;299-303.
30. Tuomi T., Groop L.C., Zimmet P.Z., Rowley M.J., Knowles W., Mackay I.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes. 42:1993;359-362.
31. Duhault J., Boulanger M., Espinal J., Marquie G., Petkov P., du Boistesselin R. Latent autoimmune diabetes mellitus in adult humans with non-insulin-dependent diabetes: is Psammomys obesus a suitable animal model? Acta Diabetol. 32:1995;92-94.
32. Roll U., Nuber A., Schroder A., Gerlach E., Janka H.U., Ziegler A.G. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM. Diabetes Care. 18:1995;210-215.
33. Vinik A.I., Leichter S.B., Pittenger G.L., Stansberry K.B., Holland M.T., Powers A.C., Suwanwalaikorn S. Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy. Diabetes Care. 18:1995;1225-1232.
34. Kobayashi T., Nakanishi K., Murase T., Kosaka K. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes. 45:1996;622-626.